SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 34 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,915 | -88.1% | 4,419 | -78.9% | 0.00% | – |
| Q3 2022 | $33,000 | -25.0% | 20,984 | -4.6% | 0.00% | – |
| Q2 2022 | $44,000 | +238.5% | 21,987 | +293.3% | 0.00% | – |
| Q1 2022 | $13,000 | +225.0% | 5,591 | +1294.3% | 0.00% | – |
| Q2 2021 | $4,000 | -99.7% | 401 | -99.9% | 0.00% | – |
| Q3 2018 | $1,599,000 | +271.9% | 363,300 | +233.9% | 0.00% | – |
| Q1 2017 | $430,000 | +20.1% | 108,789 | +164.5% | 0.00% | – |
| Q4 2015 | $358,000 | +3.8% | 41,130 | 0.0% | 0.00% | – |
| Q3 2015 | $345,000 | -52.4% | 41,130 | 0.0% | 0.00% | – |
| Q2 2015 | $725,000 | +52.6% | 41,130 | 0.0% | 0.00% | – |
| Q1 2015 | $475,000 | -75.2% | 41,130 | -90.3% | 0.00% | – |
| Q3 2014 | $1,916,000 | -55.7% | 423,800 | -33.9% | 0.00% | -100.0% |
| Q2 2014 | $4,327,000 | -48.1% | 641,100 | -1.4% | 0.00% | 0.0% |
| Q1 2014 | $8,333,000 | +58.3% | 650,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $5,265,000 | – | 650,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
| SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
| Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
| Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
| Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
| Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
| COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
| Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
| SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
| Aristides Capital LLC | 24,302 | $271,000 | 0.19% |